IRIS
GIUNTI, DEBORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.460
AS - Asia 264
SA - Sud America 40
NA - Nord America 22
AF - Africa 3
Totale 4.789
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.455
SG - Singapore 114
CN - Cina 72
VN - Vietnam 52
BR - Brasile 27
HK - Hong Kong 14
US - Stati Uniti d'America 12
MX - Messico 7
ID - Indonesia 5
AR - Argentina 4
CA - Canada 3
KE - Kenya 3
PE - Perù 3
IQ - Iraq 2
PL - Polonia 2
PT - Portogallo 2
PY - Paraguay 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
IN - India 1
IR - Iran 1
KR - Corea 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.789
Salva come PNG Salva come JPEG
Città #
Genova 2.227
Genoa 1.416
Rapallo 451
Vado Ligure 336
Singapore 46
Beijing 23
Ho Chi Minh City 18
Bordighera 14
Hong Kong 14
Hanoi 12
Ashburn 8
Turin 6
Mexico City 5
Haiphong 4
Montreal 3
Nairobi 3
Phủ Lý 3
São Paulo 3
Tianjin 3
Ananindeua 2
Asunción 2
Braga 2
Hải Dương 2
Quảng Ngãi 2
Wroclaw 2
Americana 1
Arequipa 1
Arroyo Seco 1
Baghdad 1
Baku 1
Bandung 1
Belo Horizonte 1
Bernardo do Mearim 1
Boardman 1
Bonito 1
Bragança Paulista 1
Brooklyn 1
Bucaramanga 1
Bắc Ninh 1
Campina Grande do Sul 1
Campinas 1
Canaã dos Carajás 1
Caratinga 1
Cumaná 1
Curvelo 1
Da Nang 1
Erbil 1
Fernandópolis 1
Goiânia 1
Guadalajara 1
Guangzhou 1
Guaíba 1
Ha Long 1
Houston 1
Huauchinango 1
Hyderabad 1
Isidro Casanova 1
Jakarta 1
Lima 1
Limeira 1
Milan 1
Minsk 1
Modena 1
Monte Grande 1
New York 1
Ninh Bình 1
Passo Fundo 1
Probolinggo 1
Ribeirão Preto 1
Rocca Priora 1
Santa Cruz Cabrália 1
Santa Luzia 1
Santa Teresita 1
Seongbuk-gu 1
São João da Boa Vista 1
Sóc Trăng 1
Taboão da Serra 1
Taipei 1
Taubaté 1
Thái Bình 1
Thái Nguyên 1
Tulcán 1
Utinga 1
Verona 1
Villa Alemana 1
Vĩnh Long 1
Totale 4.668
Salva come PNG Salva come JPEG
Nome #
Neuroprotective features of mesenchymal stem cells. 201
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 196
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 196
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 180
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 176
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 174
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 174
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 169
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 161
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 161
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 157
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 148
Human mesenchymal stem cells modulate B-cell functions. 140
Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 138
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 138
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis. 133
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 121
Dynamics of the reactivity to MBP in multiple sclerosis. 120
Restricted immune responses lead to CNS demyelination and axonal damage. 116
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. 112
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 112
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 109
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 109
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 109
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. 108
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 106
racterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 97
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 95
Mesenchimal stem cells exert beneficial effects on microglia 83
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 82
Mesenchymal stem cells exert their therapeutic effect by inducing microglia to acquire a neuroprotective phenotype 82
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 78
MRI and neuropathologic study of eae in the non human primate callithr1x jacchus 75
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 60
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 59
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 56
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 56
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 48
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 46
MSC-derived extracellular vesicles for the treatment of ALS 41
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 38
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 34
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 23
PD‐L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single‐center retrospective study 19
null 1
Totale 4.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.776
article - articoli 11.011
book - libri 0
conference - conferenze 4.765
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 8 14 30 20 20 15 14
2021/2022419 15 47 34 59 17 15 15 88 15 34 7 73
2022/2023521 42 51 4 50 104 73 4 30 86 7 63 7
2023/2024365 10 22 14 40 45 89 19 31 10 9 20 56
2024/2025904 61 53 25 73 89 90 62 190 28 35 82 116
2025/2026788 212 43 89 159 276 9 0 0 0 0 0 0
Totale 4.837